Search - tctmd.com

Displaying 501 - 520 of 582

Sort: Relevancy | Date

News Daily News

Low-Dose Rivaroxaban Reduces Thrombotic Events, Increases Bleeding After STEMI

Yael L. Maxwell

March 09, 2013

News Conference News ACC 2013

DEFER-STEMI: Holding Off Stenting for Several Hours Improves Outcomes

L.A. McKeown

March 08, 2013

News Daily News

Radial, Femoral PCI Show Similar Bleeding Rates in NSTE ACS Patients

L.A. McKeown

March 03, 2013

News Daily News

ROCKET AF Analysis Looks at Stroke Risk After Stopping Anticoagulation

February 04, 2013

News Daily News

Ideal Duration of Dual Antiplatelet Therapy May Depend on Stent Type

Jason Kahn

January 22, 2013

News Daily News

Endovascular Therapy for DVT Appears Safe, Effective in Registries

January 22, 2013

News Daily News

PLATO Substudy: Ticagrelor Advantage Persists After First Ischemic Event

January 07, 2013

News Daily News

JACC Letter: Hypothermia Therapy May Increase Stent Thrombosis Risk

L.A. McKeown

January 06, 2013

News Daily News

TCTMD’s Top 10 Most Popular News Stories for 2012

Jason Kahn

January 02, 2013

Presentation TCT 2012

PCI in a Thrombotic Lesion

Presenter: Kui-Hian Sim

October 25, 2012

News Industry News

8500+ Patient Trial Validates Association between High Platelet Reactivity and 1-Year Cardiovascular Outcomes at TCT 2012

October 25, 2012

News Conference News TCT 2012

Presentations Examine Multiple Facets of Antiplatelet Agents

October 24, 2012

News Conference News TCT 2012

Mesh-Covered Stent Shines in MASTER Trial

October 24, 2012

News Daily News

Meta-analysis Looks at Novel Anticoagulants Plus Dual Therapy in ACS Patients

October 02, 2012

News Daily News

PLATO Substudy: Ticagrelor Associated with Less Bleeding, Infection, Death than Clopidogrel after CABG

September 27, 2012

News Daily News

Korean Registry Confirms Edge of Everolimus- Over Zotarolimus-Eluting Stents

September 19, 2012

Presentation VEINS 2012

Primary Venous Disease versus Post-Thrombotic Syndrome

Presenter: Suman Rathbun

September 15, 2012

News Conference News ESC 2012

ESC Congress 2012: Diverse Lineup of Practice-Changing Presentations

Caitlin E. Cox

September 04, 2012

News Conference News ESC 2012

Low-Dose Rivaroxaban Curbs Thrombotic Events in STEMI Patients

Caitlin E. Cox

August 27, 2012

News Conference News ESC 2012

Prolonged Vorapaxar Enhances Secondary Prevention in Selected Post-MI Patients

August 26, 2012

Advertisement

Low-Dose Rivaroxaban Reduces Thrombotic Events, Increases Bleeding After STEMI

DEFER-STEMI: Holding Off Stenting for Several Hours Improves Outcomes

Radial, Femoral PCI Show Similar Bleeding Rates in NSTE ACS Patients

ROCKET AF Analysis Looks at Stroke Risk After Stopping Anticoagulation

Ideal Duration of Dual Antiplatelet Therapy May Depend on Stent Type

Endovascular Therapy for DVT Appears Safe, Effective in Registries

PLATO Substudy: Ticagrelor Advantage Persists After First Ischemic Event

JACC Letter: Hypothermia Therapy May Increase Stent Thrombosis Risk

TCTMD’s Top 10 Most Popular News Stories for 2012

PCI in a Thrombotic Lesion

8500+ Patient Trial Validates Association between High Platelet Reactivity and 1-Year Cardiovascular Outcomes at TCT 2012

Presentations Examine Multiple Facets of Antiplatelet Agents

Mesh-Covered Stent Shines in MASTER Trial

Meta-analysis Looks at Novel Anticoagulants Plus Dual Therapy in ACS Patients

PLATO Substudy: Ticagrelor Associated with Less Bleeding, Infection, Death than Clopidogrel after CABG

Korean Registry Confirms Edge of Everolimus- Over Zotarolimus-Eluting Stents

Primary Venous Disease versus Post-Thrombotic Syndrome

ESC Congress 2012: Diverse Lineup of Practice-Changing Presentations

Low-Dose Rivaroxaban Curbs Thrombotic Events in STEMI Patients

Prolonged Vorapaxar Enhances Secondary Prevention in Selected Post-MI Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content